Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: FluimediX Closes $1.1M Financing Round

This article has been updated to report the total amount of funding in the round.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – FluimediX today said that it has closed a round of financing intended to support further development of its NanoCycler platform.

The Taastrup, Denmark-based firm raised DKK 6 million ($1.1 million) in the round that was led by Seed Capital Denmark. In addition, existing shareholders participated in the round.

FluimediX is developing the NanoCycler, a fully-automated diagnostic platform for rapidly measuring genetic mutations in patients. According to the firm's website, the system can conduct near-patient DNA-based testing in less than 15 minutes, from sample to result.

The firm, which was founded in 2003 and has its offices at the Danish Technical Institute, said that the funds from this round of financing would be dedicated to developing a test for warfarin metabolism.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.